IKK-1/IKK-2 inhibitors (Novartis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIKK-1/IKK-2 inhibitors (Novartis)
Drug Alias NameNVP-IKK-004NVP-IKK-005
ClassificationSmall molecules
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsProtein kinases inhibitorsImmunosuppressants
TargetsProtein kinasesNuclear factor NF-kappa-B complex
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A